Transcat (TRNS): executive pay, fiscal 2026

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Transcat Inc’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

CEO total pay$5,862,200Former CEO Lee Rudow · source

Say-on-pay support98.1%Latest vote · source

CEO vs. named peers50th pct.Of 16 peer CEOs

CEO pay ratio87:1To the median employee · source

CEO pay, last three years

$2,440,460FY2024
$1,815,360FY2025
$5,862,200FY2026

CEO total pay was $5,862,200 in fiscal 2026, up from $1,815,360 in fiscal 2025.

FY2026: salary $737,000 · bonus $0 · stock awards $4,613,932 · option awards $0

Executives and directors

Lee Rudow · CEO Michael Haddad · Chief Information Officer Michael West · COO Theresa Conroy · Chief Human Resources Officer Thomas Barbato · CFO Charles P. Hadeed · Former director (through FY2026)Christopher P. Gillette · Independent Director Craig D. Cairns · Independent Director Cynthia M. Langston · Independent Director Dawn G. DePerrior · Independent Director Gary J. Haseley · Chair of the Board Jaime A. Irick · Director Mbago M. Kaniki · Independent Director Oksana S. Dominach · Independent Director Robert L. Mecca · Independent Director

Frequently asked questions

Who was the highest-paid executive at Transcat Inc in fiscal 2026?

As disclosed, Lee Rudow (Former President and Chief Executive Officer) was the highest-paid executive at Transcat Inc in fiscal 2026, with total compensation of $5,862,200.

How does Transcat Inc's chief executive pay compare to its disclosed peer group?

As disclosed, Lee Rudow's total compensation ranked at the 50th percentile of Transcat Inc's disclosed peer group.

What is Transcat Inc's CEO-to-median employee pay ratio?

As disclosed, Transcat Inc's CEO-to-median employee pay ratio was 87:1.

How did shareholders vote on Transcat Inc's executive compensation?

As disclosed, 98.1% of shareholders supported Transcat Inc's executive compensation in the latest say-on-pay vote.

How much does Transcat Inc spend in total on board compensation for fiscal 2026?

As disclosed, Transcat Inc reported total board compensation of $1,635,697 for fiscal 2026.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table

Named executive officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension / NQDC	All other	Total
Lee Rudow	$737,000	$0	$4,613,932	$0	$494,115	$0	$17,153	$5,862,200
Former President and Chief Executive Officer
Thomas Barbato	396,000	0	1,695,231	0	132,544	0	11,625	2,235,400
Chief Financial Officer and Treasurer
Michael West	363,000	0	966,521	0	97,408	0	11,617	1,438,546
Chief Operating Officer
Theresa Conroy	311,000	0	832,082	0	83,214	0	10,294	1,236,590
Chief Human Resources Officer
Michael Haddad	312,000	0	502,099	0	83,492	0	9,922	907,513
Chief Information Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officer	FY2026 total	FY2025 total	FY2024 total	Δ FY2025→2026
Lee Rudow	$5,862,200	$1,815,360	$2,440,460	↑ +4,046,840
Thomas Barbato	2,235,400	922,852	994,829	↑ +1,312,548
Michael West	1,438,546	848,869	619,363	↑ +589,677
Theresa Conroy	1,236,590	536,039	596,967	↑ +700,551
Michael Haddad	907,513	367,727	—	↑ +539,786

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

Our compensation program is designed to attract, motivate and retain a highly-qualified and effective executive management team. We believe that the most effective executive compensation program is one that is designed to reward the achievement of specific annual, long-term and strategic company goals, which aligns the interests of each of our executive management team with those of our shareholders.

CEO STI target (% of salary)	100%
CEO LTI target (% of salary)	—
Independent consultant	Frederic W. Cook & Company, Inc.
Clawback policy	True
Anti-hedging	True
Anti-pledging	False

Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2026

Executive	Award	Grant date	Threshold	Target	Granted	Maximum	Grant-date fair value
Michael West	RSU	2025-05-27	—	—	1,285	—	$118,271
Michael Haddad	RSU	2026-01-06	—	—	5,190	—	314,981
Theresa Conroy	RSU	2025-05-27	—	—	1,098	—	101,060
Theresa Conroy	RSU	2026-01-06	—	—	10,380	—	629,962
Lee Rudow	RSU	2025-08-21	—	—	14,782	—	1,249,966
Michael West	RSU	2026-01-06	—	—	12,028	—	729,979
Lee Rudow	RSU	2025-08-21	—	—	12,500	—	1,057,000
Lee Rudow	PSU	2025-08-21	6,250	12,500	—	18,750	1,057,000
Theresa Conroy	PSU	2025-05-27	549	1,098	—	1,647	101,060
Thomas Barbato	RSU	2026-01-06	—	—	19,772	—	1,199,963
Thomas Barbato	RSU	2025-05-27	—	—	2,691	—	247,680
Michael West	PSU	2025-05-27	643	1,285	—	1,928	118,271
Thomas Barbato	PSU	2025-05-27	1,345	2,690	—	4,035	247,588
Michael Haddad	RSU	2025-05-27	—	—	1,017	—	93,605
Michael Haddad	PSU	2025-05-27	508	1,016	—	1,524	93,513
Lee Rudow	PSU	2025-08-21	7,391	14,782	—	22,173	1,249,966

Vehicle mix — grant-date fair value by award type

Named executive officer	Time-vested (RSU)	Performance-vested (PSU)	Options / SARs	% performance-vested
Michael West	$848,250	$118,271	$0	12.2%
Michael Haddad	408,586	93,513	0	18.6%
Theresa Conroy	731,022	101,060	0	12.1%
Lee Rudow	2,306,966	2,306,966	0	50.0%
Thomas Barbato	1,447,643	247,588	0	14.6%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2026

Executive	Award	Shares unvested	Exercise price	Market value unvested
Theresa Conroy	PSU	524	—	$37,372
Michael West	PSU	725	—	51,707
Michael Haddad	RSU	730	—	52,064
Michael Haddad	PSU	730	—	52,064
Theresa Conroy	PSU	782	—	55,772
Theresa Conroy	RSU	783	—	55,844
Michael West	RSU	916	—	65,329
Michael West	PSU	916	—	65,329
Michael Haddad	PSU	1,016	—	72,532
Michael Haddad	RSU	1,017	—	72,532
Theresa Conroy	RSU	1,098	—	78,309
Theresa Conroy	PSU	1,098	—	78,309
Thomas Barbato	PSU	1,186	—	84,586
Michael West	RSU	1,285	—	91,718
Michael West	PSU	1,285	—	91,718
Thomas Barbato	PSU	1,918	—	136,792
Thomas Barbato	RSU	1,919	—	136,863
Michael West	RSU	2,000	—	142,640
Thomas Barbato	PSU	2,690	—	191,922
Thomas Barbato	RSU	2,691	—	191,922
Lee Rudow	PSU	3,784	—	269,875
Lee Rudow	RSU	3,925	—	279,931
Lee Rudow	PSU	3,925	—	279,931
Michael Haddad	RSU	5,190	—	370,151
Lee Rudow	RSU	8,333	—	594,310
Theresa Conroy	RSU	10,380	—	740,302
Michael West	RSU	12,028	—	857,837
Lee Rudow	PSU	12,500	—	891,500
Lee Rudow	RSU	14,782	—	1,054,252
Lee Rudow	PSU	14,782	—	1,054,252
Thomas Barbato	RSU	19,772	—	1,410,139

Director compensation

Director	Cash fees	Stock awards	Option awards	Non-equity incentive	All other	Total
Gary J. HaseleyIndependent · Board Chair · Executive (Chair)	$135,000	$120,009	$0	—	$0	$255,009
Mbago M. KanikiIndependent · Audit · Executive · NESG (Chair)	105,000	120,009	0	—	0	225,009
Oksana S. DominachIndependent · Audit (Chair) · Compensation · Executive	95,000	120,009	0	—	0	215,009
Craig D. CairnsIndependent · Compensation (Chair)	70,000	120,009	0	—	0	190,009
Cynthia M. LangstonIndependent · Audit · Technology (Chair)	70,000	120,009	0	—	0	190,009
Dawn G. DePerriorIndependent · Compensation · NESG · Technology	60,625	120,009	0	—	0	180,634
Christopher P. GilletteIndependent · Compensation · NESG · Technology	60,625	120,009	0	—	0	180,634
Robert L. MeccaIndependent · Audit	55,000	120,009	0	—	0	175,009
Charles P. HadeedIndependent · Not standing for re-election · Departed during FY	24,375	—	0	—	0	24,375
Jaime A. IrickEmployee director · Partial-year service · Newly elected	0	0	0	—	0	0

Board fee structure and ownership guideline

Annual cash retainer	$55,000
Annual equity retainer	$120,000
Per board meeting fee	—
Committee chair fees (audit / comp / nom-gov)	20,000 / 15,000 / 15,000
Stock ownership guideline	3.0x annual cash retainer

Total cost of the board

Component	FY2026
Cash retainers and fees	$675,625
Equity awards (grant-date value)	$960,072
All other compensation	$0
Total cost of the board	$1,635,697

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Transcat as a peer

Companies that benchmark against TRNS

5 companies name TRNS as a compensation peer

Each company listed discloses TRNS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named TRNS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Disclosed peer group — fiscal year 2026

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

CTKB Cytek Biosciences, Inc.AVAV AeroVironment, Inc.AGX Argan, Inc.CYRX Cryoport, Inc.DCO Ducommun IncorporatedGHM Graham CorporationLMAT LeMaitre Vascular, Inc.LGND Ligand Pharmaceuticals IncorporatedOFLX Omega Flex, Inc.POWL Powell Industries, Inc.SXI Standex International CorporationWLFC Willis Lease Finance CorporationMLAB Mesa Laboratories, Inc.TCMD Tactile Systems Technology, Inc.AXSM Axsome Therapeutics, Inc.SRDX Surmodics, Inc.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

Rank	Company	FY	Chief executive	Salary	Stock awards	Option awards	Non-equity incentive	Total
1	Willis Lease Finance Corporation	2025	Austin Willis	$850,662	$14,637,060	$0	$0	$19,209,005
2	AeroVironment, Inc.	2026	Wahid Nawabi	1,118,829	13,339,715	0	767,609	15,253,775
3	Ligand Pharmaceuticals Incorporated	2025	Todd Davis	724,500	5,520,493	4,441,120	764,400	11,472,095
4	Ducommun Incorporated	2025	Stephen Oswald	1,019,624	6,121,650	—	3,058,871	10,329,989
5	Axsome Therapeutics, Inc.	2025	Herriot Tabuteau	835,000	5,533,554	2,833,237	876,750	10,283,492
6	Mesa Laboratories, Inc.	2026	Gary Owens	808,846	4,700,017	0	1,120,000	6,643,208
7	Standex International Corporation	2026	David Dunbar	936,436	4,135,819	0	560,457	6,407,973
8	Transcat Inc	2026	Lee Rudow	737,000	4,613,932	0	494,115	5,862,200
9	Cytek Biosciences, Inc.	2025	Wenbin Jiang	620,000	2,000,000	2,000,000	485,211	5,120,061
10	LeMaitre Vascular, Inc.	2025	George LeMaitre	806,347	1,050,000	1,050,000	680,015	3,780,990
11	Surmodics, Inc.	2024	Gary Maharaj	647,481	940,000	1,410,000	654,215	3,665,496
12	Powell Industries, Inc.	2025	Brett Cope	660,000	1,129,268	0	1,650,000	3,600,369
13	Tactile Systems Technology, Inc.	2025	Sheri Dodd	675,000	2,019,978	0	737,438	3,466,916
14	Argan, Inc.	2026	David Watson	500,000	1,547,260	86,500	0	2,668,098
15	Cryoport, Inc.	2025	Jerrell Shelton	967,845	192,300	306,869	908,510	2,375,524
16	Graham Corporation	2026	Matthew Malone	462,769	600,004	0	636,308	1,809,120
17	Omega Flex, Inc.	2025	Dean Rivest	559,728	150,750	0	300,000	1,063,560

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Incentive design against the same peers

Company	Annual incentive payout	Long-term vehicle mix	PSU measures include TSR	Compensation consultant
Transcat Inc	67%	PSU 50 · RSU 50	No	Frederic W. Cook & Company, Inc.
AeroVironment, Inc.	62%	PSU 65 · RSU 35	No	Pay Governance
Argan, Inc.	not disclosed	not disclosed	not disclosed	not disclosed
Axsome Therapeutics, Inc.	150%	RSU 33 · Options 33 · PSU 33	No	Frederic W. Cook & Co., Inc.
Cryoport, Inc.	92.2%	not disclosed	not disclosed	Frederic W. Cook & Co., Inc.
Cytek Biosciences, Inc.	78.4%	RSU 50 · Options 50	not disclosed	Meridian Compensation Partners, LLC
Ducommun Incorporated	not disclosed	not disclosed	not disclosed	Willis Towers Watson LLC
Graham Corporation	not disclosed	RSU 50 · PSU 50	not disclosed	Frederic W. Cook & Co., Inc.
LeMaitre Vascular, Inc.	not disclosed	Option 50 · RSU 25 · PSU 25	No	not disclosed
Ligand Pharmaceuticals Incorporated	150%	not disclosed	No	Aon
Mesa Laboratories, Inc.	125%	PSU 50 · RSU 50	No	Frederic W. Cook & Co, Inc.
Omega Flex, Inc.	not disclosed	not disclosed	not disclosed	not disclosed
Powell Industries, Inc.	200%	RSU 50 · PRSU 50	No	not disclosed
Standex International Corporation	not disclosed	RSU 50 · PSU 50	Yes — Relative TSR	Meridian
Surmodics, Inc.	126.3%	Option 60 · Restricted Shares 40	not disclosed	Pay Governance LLC
Tactile Systems Technology, Inc.	115%	PSU 50 · RSU 50	No	Aon Consulting, Inc.
Willis Lease Finance Corporation	not disclosed	PSU 60 · RSU 40	not disclosed	Exequity, LLP

Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.

Say-on-pay history and pay ratio

Meeting year	Meeting date	For	Against	Abstain	Support	Outcome
2026	2026-09-09	7,921,274	153,061	4,421	98.1%	Passed
2025	2025-09-10	7,842,250	75,934	4,704	99.04%	Passed
2024	2024-09-11	7,850,677	252,100	26,084	96.89%	Passed
2023	2023-09-06	6,603,935	119,485	17,142	98.22%	Passed
2022	2022-09-07	5,909,671	36,551	27,750	99.39%	Passed
2021	2021-09-08	6,164,404	168,557	15,058	97.34%	Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting year	Meeting date	Approval — company’s computation
2026	2026-09-09	98.1%^a
2025	2025-09-10	99.04%^b
2024	2024-09-11	96.89%^c

a. Voting standard not stated in the filing.

b. Approved under the standard stated in the filing — “Thus, abstentions will have no effect on the outcome of the vote on the proposals requiring the approval of a plurality or a majority of votes duly cast (Proposals One, Three, Four, and Five), because abstentions are not counted as votes duly cast.”.

c. Approved under the standard stated in the filing — “Thus, abstentions will have no effect on the outcome of the vote on the proposals requiring the approval of a plurality or a majority of votes duly cast (Proposals One, Two and Three), because abstentions are not counted as votes duly cast.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)	87 : 1
CEO total compensation	$5,862,200
Median employee compensation	$67,600

Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2026 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

Insider	Role	Transaction date	Code	Shares	Price	Value	Security	Source
Craig D. Cairns	Director	2026-08-06	A	1,050	$94	$98,663	Common	Form 4 ↗
Christopher P. Gillette	Director	2026-08-07	D	504	94	47,494	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-08-13	D	10,000	0	0	Derivative, Class A Common	Form 4 ↗
Oksana S. Dominach	Director	2026-08-13	D	2,688	98	262,779	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-08-13	A	10,000	26	262,700	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-09-02	D	7,312	86	625,876	Common	Form 4 ↗
Dividend-equivalent accruals		2026-09-09	—	13,368	—	—	8 insiders, 8 accrual rows
Craig D. Cairns	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Christopher P. Gillette	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Dividend-equivalent accruals		2026-09-10	—	12,696	—	—	8 insiders, 8 accrual rows
Cynthia M. Langston	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Robert L. Mecca	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Dawn G. DePerrior	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Mbago M. Kaniki	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Gary J. Haseley	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 30 transactions

Insider	Role	Transaction date	Code	Shares	Price	Value	Security	Source
Craig D. Cairns	Director	2026-08-06	A	1,050	$94	$98,663	Common	Form 4 ↗
Christopher P. Gillette	Director	2026-08-07	D	504	94	47,494	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-08-13	D	10,000	0	0	Derivative, Class A Common	Form 4 ↗
Oksana S. Dominach	Director	2026-08-13	D	2,688	98	262,779	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-08-13	A	10,000	26	262,700	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-09-02	D	7,312	86	625,876	Common	Form 4 ↗
Craig D. Cairns	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Mbago M. Kaniki	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Cynthia M. Langston	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Oksana S. Dominach	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Robert L. Mecca	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Gary J. Haseley	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Dawn G. DePerrior	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Christopher P. Gillette	Director	2026-09-09	A	1,671	0	0	Derivative, Class A Common	Form 4 ↗
Craig D. Cairns	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Christopher P. Gillette	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Mbago M. Kaniki	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗
Cynthia M. Langston	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Robert L. Mecca	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Dawn G. DePerrior	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗
Robert L. Mecca	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗
Craig D. Cairns	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗
Dawn G. DePerrior	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Oksana S. Dominach	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗
Mbago M. Kaniki	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Christopher P. Gillette	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗
Gary J. Haseley	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗
Gary J. Haseley	Director	2026-09-10	A	1,587	0	0	Common	Form 4 ↗
Cynthia M. Langston	Director	2026-09-10	D	1,587	0	0	Derivative, Class A Common	Form 4 ↗

Sources (85 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

Section 01, Lee Rudow. DEF 14A, filed 2026-07-23. Section “2026 Summary Compensation Table” · page 34. As printed: 5,862,200. View filing ↗
Section 01, Thomas Barbato. DEF 14A, filed 2026-07-23. Section “2026 Summary Compensation Table”. As printed: 2,235,400. View filing ↗
Section 01, Michael West. DEF 14A, filed 2026-07-23. Section “2026 Summary Compensation Table”. As printed: 1,438,546. View filing ↗
Section 01, Theresa Conroy. DEF 14A, filed 2026-07-23. Section “2026 Summary Compensation Table”. As printed: 1,236,590. View filing ↗
Section 01, Michael Haddad. DEF 14A, filed 2026-07-23. Section “2026 Summary Compensation Table”. As printed: 907,513. View filing ↗
Section 03, Michael West RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Michael Haddad RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Theresa Conroy RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Theresa Conroy RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Lee Rudow RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Michael West RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Lee Rudow RSU. DEF 14A. Section “TABLE OF CONTENTS COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. View filing ↗
Section 03, Lee Rudow PSU. DEF 14A. Section “TABLE OF CONTENTS COMPENSATION DISCUSSION AND ANALYSIS” · grants of plan-based awards table. View filing ↗
Section 03, Theresa Conroy PSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Thomas Barbato RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Thomas Barbato RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Michael West PSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Thomas Barbato PSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Michael Haddad RSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Michael Haddad PSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 03, Lee Rudow PSU. DEF 14A, filed 2026-07-23. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
Section 07, pay ratio. DEF 14A, filed 2026-07-23. Section “CEO Pay Ratio”. As printed: 87 : 1. View filing ↗
Section 08, Gary J. Haseley. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 255,009. View filing ↗
Section 08, Mbago M. Kaniki. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 225,009. View filing ↗
Section 08, Oksana S. Dominach. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 215,009. View filing ↗
Section 08, Craig D. Cairns. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 190,009. View filing ↗
Section 08, Cynthia M. Langston. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 190,009. View filing ↗
Section 08, Dawn G. DePerrior. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 180,634. View filing ↗
Section 08, Christopher P. Gillette. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 180,634. View filing ↗
Section 08, Robert L. Mecca. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 175,009. View filing ↗
Section 08, Charles P. Hadeed. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 24,375. View filing ↗
Section 08, Jaime A. Irick. DEF 14A, filed 2026-07-23. Section “Director Compensation”. As printed: 0. View filing ↗
Section 02, Craig D. Cairns 2026-08-06. Form 4, filed 2026-08-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Christopher P. Gillette 2026-08-07. Form 4, filed 2026-08-12. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Oksana S. Dominach 2026-08-13. Form 4, filed 2026-08-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Oksana S. Dominach 2026-08-13. Form 4, filed 2026-08-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Oksana S. Dominach 2026-08-13. Form 4, filed 2026-08-17. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Oksana S. Dominach 2026-09-02. Form 4, filed 2026-09-03. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Craig D. Cairns 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Mbago M. Kaniki 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Cynthia M. Langston 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Oksana S. Dominach 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Robert L. Mecca 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Gary J. Haseley 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Dawn G. DePerrior 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Christopher P. Gillette 2026-09-09. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Craig D. Cairns 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Oksana S. Dominach 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Christopher P. Gillette 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Mbago M. Kaniki 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Cynthia M. Langston 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Robert L. Mecca 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Dawn G. DePerrior 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Robert L. Mecca 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Craig D. Cairns 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Dawn G. DePerrior 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Oksana S. Dominach 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Mbago M. Kaniki 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Christopher P. Gillette 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Gary J. Haseley 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Gary J. Haseley 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 02, Cynthia M. Langston 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
Section 06, 2026 vote. Form 8-K, filed 2026-09-10. Item 5.07 · say-on-pay result. As reported: 98.1% (votes for as printed: 7,921,274). View filing ↗
Section 06, 2025 vote. Form 8-K, filed 2025-09-11. Item 5.07 · say-on-pay result. As reported: 99.04% (votes for as printed: 7,842,250). View filing ↗
Section 06, 2024 vote. Form 8-K, filed 2024-09-13. Item 5.07 · say-on-pay result. As reported: 96.89% (votes for as printed: 7,850,677). View filing ↗
Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
Section 09b board cost (computed). Computed. Cash 675,625 + equity 960,072 + all other 0 = 1,635,697, summed across the director compensation table rows.
Willis Lease Finance Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Willis Lease Finance Corporation's own proxy. As printed: 19,209,005. View filing ↗
AeroVironment, Inc., Section 10b CEO total. DEF 14A, filed 2026-08-14. CEO total compensation as printed in AeroVironment, Inc.'s own proxy. As printed: 15,253,775. View filing ↗
Ligand Pharmaceuticals Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in Ligand Pharmaceuticals Incorporated's own proxy. As printed: 11,472,095. View filing ↗
Ducommun Incorporated, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in Ducommun Incorporated's own proxy. As printed: 10,329,989. View filing ↗
Axsome Therapeutics, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Axsome Therapeutics, Inc.'s own proxy. As printed: 10,283,492. View filing ↗
Mesa Laboratories, Inc., Section 10b CEO total. DEF 14A, filed 2026-07-22. CEO total compensation as printed in Mesa Laboratories, Inc.'s own proxy. As printed: 6,643,208. View filing ↗
Standex International Corporation, Section 10b CEO total. DEF 14A, filed 2026-09-04. CEO total compensation as printed in Standex International Corporation's own proxy. As printed: 6,407,973. View filing ↗
Transcat Inc (subject), Section 10b CEO total. DEF 14A, filed 2026-07-23. CEO total compensation as printed in Transcat Inc's own proxy. As printed: 5,862,200. View filing ↗
Cytek Biosciences, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Cytek Biosciences, Inc.'s own proxy. As printed: 5,120,061. View filing ↗
LeMaitre Vascular, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-14. CEO total compensation as printed in LeMaitre Vascular, Inc.'s own proxy. As printed: 3,780,990. View filing ↗
Surmodics, Inc., Section 10b CEO total. DEF 14A, filed 2024-12-19. CEO total compensation as printed in Surmodics, Inc.'s own proxy. As printed: 3,665,496. View filing ↗
Powell Industries, Inc., Section 10b CEO total. DEF 14A, filed 2026-01-06. CEO total compensation as printed in Powell Industries, Inc.'s own proxy. As printed: 3,600,369. View filing ↗
Tactile Systems Technology, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Tactile Systems Technology, Inc.'s own proxy. As printed: 3,466,916. View filing ↗
Argan, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in Argan, Inc.'s own proxy. As printed: 2,668,098. View filing ↗
Cryoport, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Cryoport, Inc.'s own proxy. As printed: 2,375,524. View filing ↗
Graham Corporation, Section 10b CEO total. DEF 14A, filed 2026-07-14. CEO total compensation as printed in Graham Corporation's own proxy. As printed: 1,809,120. View filing ↗
Omega Flex, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Omega Flex, Inc.'s own proxy. As printed: 1,063,560. View filing ↗